Prucalopride for constipation

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

(2010) J. F. JOHANSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

5-HT4 receptor agonists: similar but not the same

(2010) J. H. De Maeyer et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Selective desensitization of the 5-HT4receptor-mediated response in pig atrium but not in stomach

(2009) JH De Maeyer et al.   BRITISH JOURNAL OF PHARMACOLOGY

This Month in Gastroenterology

(2009) Jan Tack et al.   GASTROENTEROLOGY

T1265 Cardiovascular Safety of Prucalopride in Healthy Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trials

(2009) Malcolm J. Boyce et al.   GASTROENTEROLOGY

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study

(2009) m. camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study

(2008) E. M. M. QUIGLEY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ambulatory Care for Constipation in the United States, 19932004

(2008) Nilay D. Shah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

934 Evaluation of the Efficacy, Safety and Tolerability of Prucalopride (Resolor®) Given Subcutaneously in Patients Undergoing Elective Partial Colectomies

(2008) Susan Galandiuk et al.   GASTROENTEROLOGY

642 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety of Prucalopride (Resolor®) in Patients with Opioid-Induced Constipation

(2008) Dwight E. Moulin et al.   GASTROENTEROLOGY

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

(2008) J Tack et al.   GUT

Synergy between 5-HT4receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach

(2008) s. cellek et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

(2008) Michael Camilleri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation

(2007) John F Johanson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY